To assess its relevance in metabolic disorders, we investigated if vigilin was deregulated in obese, insulin-resistant mice and measured its expression in livers of diet-induced obese C57Bl/6J (DIO) as well as ob/ob mice (Supplementary Fig. 1a–c). The gene discussed is HDLBP; the disease is Other metabolic disease.